These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Detection of multiple reactive protein species by immunoblotting after recombinant outer surface protein A lyme disease vaccination. Molloy PJ; Berardi VP; Persing DH; Sigal LH Clin Infect Dis; 2000 Jul; 31(1):42-7. PubMed ID: 10913394 [TBL] [Abstract][Full Text] [Related]
24. DNA vaccines expressing a fusion product of outer surface proteins A and C from Borrelia burgdorferi induce protective antibodies suitable for prophylaxis but Not for resolution of Lyme disease. Wallich R; Siebers A; Jahraus O; Brenner C; Stehle T; Simon MM Infect Immun; 2001 Apr; 69(4):2130-6. PubMed ID: 11254567 [TBL] [Abstract][Full Text] [Related]
25. Detection of Lyme disease after OspA vaccine. Schutzer SE; Luan J; Coyle PK N Engl J Med; 1997 Sep; 337(11):794-5. PubMed ID: 9289653 [No Abstract] [Full Text] [Related]
26. [Prevention of Lyme disease]. Kondrusik M; Zajkowska J; Pancewicz S; Hermanowska-Szpakowicz T Med Pr; 1999; 50(4):321-4. PubMed ID: 10582211 [TBL] [Abstract][Full Text] [Related]
27. Diagnosing canine borreliosis. Hancock D; Jenkins SR; Dennis DT J Am Vet Med Assoc; 1993 Sep; 203(5):610-1; author reply 612-4. PubMed ID: 8292154 [No Abstract] [Full Text] [Related]
28. Immunization against Lyme disease--an important first step. Steigbigel RT; Benach JL N Engl J Med; 1998 Jul; 339(4):263-4. PubMed ID: 9673306 [No Abstract] [Full Text] [Related]
29. More on diagnosis of canine borreliosis. Sonneborn-Turetsky JH J Am Vet Med Assoc; 1993 Dec; 203(11):1521-2. PubMed ID: 8288468 [No Abstract] [Full Text] [Related]
30. Perspective on the development of vaccines against Lyme disease. Edelman R Vaccine; 1991 Aug; 9(8):531-2. PubMed ID: 1771965 [TBL] [Abstract][Full Text] [Related]
31. Current understanding of Borrelia burgdorferi infection, with emphasis on its prevention in dogs. Kazmierczak JJ; Sorhage FE J Am Vet Med Assoc; 1993 Dec; 203(11):1524-8. PubMed ID: 8288471 [No Abstract] [Full Text] [Related]
32. New vaccines for infectious diseases. Waterman S; Fritz C West J Med; 1998 Dec; 169(6):370-1. PubMed ID: 9866435 [No Abstract] [Full Text] [Related]
33. Borrelia burgdorferi strain 25015: characterization of outer surface protein A and vaccination against infection. Fikrig E; Barthold SW; Persing DH; Sun X; Kantor FS; Flavell RA J Immunol; 1992 Apr; 148(7):2256-60. PubMed ID: 1545130 [TBL] [Abstract][Full Text] [Related]
34. Reactogenicity and immunogenicity of a Lyme disease vaccine in children 2-5 years old. Beran J; De Clercq N; Dieussaert I; Van Hoecke C Clin Infect Dis; 2000 Dec; 31(6):1504-7. PubMed ID: 11096024 [TBL] [Abstract][Full Text] [Related]
35. A new approach to a Lyme disease vaccine. Livey I; O'Rourke M; Traweger A; Savidis-Dacho H; Crowe BA; Barrett PN; Yang X; Dunn JJ; Luft BJ Clin Infect Dis; 2011 Feb; 52 Suppl 3():s266-70. PubMed ID: 21217174 [TBL] [Abstract][Full Text] [Related]
36. Keeping Lyme disease at bay. An integrated approach to prevention. Wade CF Am J Nurs; 2000 Jul; 100(7):26-31; quiz 32. PubMed ID: 10914066 [No Abstract] [Full Text] [Related]
37. Effect of immunization with recombinant OspA on serologic tests for Lyme borreliosis. Fawcett PT; Rose CD; Budd SM; Gibney KM Clin Diagn Lab Immunol; 2001 Jan; 8(1):79-84. PubMed ID: 11139199 [TBL] [Abstract][Full Text] [Related]
38. Lyme disease: a multifocal worldwide epidemic. Sigal LH; Curran AS Annu Rev Public Health; 1991; 12():85-109. PubMed ID: 2049148 [No Abstract] [Full Text] [Related]
39. From the Food and Drug Administration. Nightingale SL JAMA; 1999 Feb; 281(5):408. PubMed ID: 9952188 [No Abstract] [Full Text] [Related]
40. Lyme borreliosis vaccination: the facts, the challenge, the future. Schuijt TJ; Hovius JW; van der Poll T; van Dam AP; Fikrig E Trends Parasitol; 2011 Jan; 27(1):40-7. PubMed ID: 20594913 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]